RNF181 modulates Hippo signaling and triple negative breast cancer progression.
Rui ZhouYinlu DingMin XueBin XiongTing ZhuangPublished in: Cancer cell international (2020)
Our study provides evidence to establish a non-proteolytic mechanism in modulating Hippo signaling in breast cancer. RNF181 could be an interesting marker for triple negative breast cancer prognostics and therapeutics.